Citalopram Hydrobromide/Mecamylamine Hydrochloride

氢溴酸西酞普兰/盐酸美加明

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCitalopram Hydrobromide/Mecamylamine Hydrochloride
Drug Alias Name氢溴酸西酞普兰+盐酸美加明Mecamylamine Hydrochloride+Citalopram Hydrobromide盐酸美加明+氢溴酸西酞普兰Citalopram Hydrobromide+Mecamylamine HydrochlorideMecamylamine Hydrochloride/Citalopram Hydrobromide +[6] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin transporter inhibitorsAcetylcholine receptor; alpha1/beta1/delta/gamma antagonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gammaSerotonin transporter
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Mecamylamine HydrochlorideCitalopram Hydrobromide
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of South Florida
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargacept PharmaLayton Bioscience IncUniversity Of South Florida
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A